Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$21.92 - $84.91
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $12.87B |
EV | $12.75B |
Shares Outstanding | 205.92M |
Beta | 1.07 |
Analyst Rating | BUY |
Analyst Target Price | $97.18 |
P/E 2025E | - |
P/Revenue 2025E | 27.52x |
Revenue | 24.50% |
EPS | -12.80% |
Operating Cash Flow | -23.50% |
Free Cash Flow | -24.00% |
Revenue | 72.00% |
EPS | 48.30% |
Operating Cash Flow | 30.40% |
Free Cash Flow | 59.00% |
Gross Margin 2025E | 77.21% |
Net Profit Margin 2025E | -209.34% |
ROE 2025E | -744.24% |
ROCE 2024 | - |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Insmed Incorporated
INSM
Sector
Healthcare
Industry
Biotechnology
CEO
Lewis, William
Employees
1,271
Website
www.insmed.comIPO Date
2000-06-01
Headquarters
700 US Highway 202/206, Bridgewater, New Jersey, 08807, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved